Homburger has advised PolyPeptide Group AG. Lenz & Staehelin has advised Draupnir Holding B.V., PolyPeptide’s largest shareholder. Samsung Biologics has launched an all-cash public tender offer...
Samsung Biologics to Acquire PolyPeptide via CHF 1.46 Billion Public Tender Offer
PolyPeptide AG’s €40 Million Revolving Credit Facility Increasing
Niederer Kraft Frey advised PolyPeptide Group AG on the deal. PolyPeptide Group AG secured additional financing under its revolving credit facility, as well as further support...
PolyPeptide AG’s €111 Million Revolving Credit Facility
Niederer Kraft Frey advised PolyPeptide on the deal. PolyPeptide has completed its inaugural EUR 111 million three-year revolving credit facility with Credit Suisse, Danske Bank and Zürcher...



























